Literature DB >> 20655064

The role of matrix metalloproteinases in intestinal epithelial wound healing during normal and inflammatory states.

Dana M Hayden1, Christopher Forsyth, Ali Keshavarzian.   

Abstract

BACKGROUND: Healing of the epithelium is a key consideration in gastrointestinal surgery. Inflammation is one factor innate to patients with inflammatory bowel disease that poses a risk of delayed healing of the intestinal epithelium postoperatively.
MATERIALS AND METHODS: Epithelial wounding model was performed on rat intestinal epithelial cells grown under control and interferon gamma (IFN-γ)-, interleukin-1beta (IL-1β)-, and tumor necrosis factor-alpha (TNF-α)-stimulated conditions. Wounds were measured and percent healing was calculated at 0, 8 and 24 h. Western blot analysis was performed using matrix metalloproteinase (MMP)-7 primary antibody and semiquantitative densitometry was conducted.
RESULTS: Wounds were 50.0% and 99.7% healed under control conditions at 8 and 24 h, respectively. IL-1β and IFN-γ delayed wound closure. MMP-7 increased by 2.3-fold at 8 h and 1.6-fold at 24 h during wound healing. Activated MMP-7 increased by 3- to 5-fold at 24 h. IL-1β stimulation increased levels of MMP-7 by 17% to 37% above the elevated expression due to healing alone. TNF-α up-regulated MMP-7 in non-wounded and wounded cells, and IFN-γ did not affect its expression. When MMP-7 activity was blocked, wound closure was delayed.
CONCLUSIONS: MMP-7 significantly contributes to intestinal epithelial wound closure evidenced by: (1) presence of increased MMP-7 during healing under control conditions and (2) the delayed rate of closure when MMP-7 activity was blocked. IL-1β increased MMP-7 levels beyond those seen during normal healing. It appears that some increase in MMP-7 is necessary for normal wound closure; however, its overexpression may delay intestinal epithelial wound healing, especially when MMP-7 is up-regulated by cytokines present in the inflammatory environment of inflammatory bowel disease (IBD).
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20655064     DOI: 10.1016/j.jss.2010.03.002

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  19 in total

1.  Selective matrix metalloproteinase inhibition increases breaking strength and reduces anastomotic leakage in experimentally obstructed colon.

Authors:  Peter-Martin Krarup; Mikkel Eld; Lars Nannestad Jorgensen; Mark Berner Hansen; Magnus S Ågren
Journal:  Int J Colorectal Dis       Date:  2017-07-17       Impact factor: 2.571

Review 2.  Is there new hope for therapeutic matrix metalloproteinase inhibition?

Authors:  Roosmarijn E Vandenbroucke; Claude Libert
Journal:  Nat Rev Drug Discov       Date:  2014-11-07       Impact factor: 84.694

3.  Effect of the natural flavonoids myricetin and dihydromyricetin on the wound healing process in vitro.

Authors:  Renata Sklenarova; Marika Svrckova; Petr Hodek; Jitka Ulrichova; Jana Frankova
Journal:  J Appl Biomed       Date:  2021-08-10       Impact factor: 1.797

4.  Matrix metalloproteinases in the restorative proctocolectomy pouch of pediatric ulcerative colitis.

Authors:  Laura Mäkitalo; Maija Piekkala; Merja Ashorn; Mikko Pakarinen; Antti Koivusalo; Riitta Karikoski; Johanna Natunen; Ulpu Saarialho-Kere; Risto Rintala; Kaija-Leena Kolho
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

Review 5.  Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease.

Authors:  Emilio G Quetglas; Zlatan Mujagic; Simone Wigge; Daniel Keszthelyi; Sebastian Wachten; Ad Masclee; Walter Reinisch
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

Review 6.  Impact of proteolytic enzymes in colorectal cancer development and progression.

Authors:  László Herszényi; Loránd Barabás; István Hritz; Gábor István; Zsolt Tulassay
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

Review 7.  Matrix metalloproteinases in inflammatory bowel disease: an update.

Authors:  Shane O'Sullivan; John F Gilmer; Carlos Medina
Journal:  Mediators Inflamm       Date:  2015-04-08       Impact factor: 4.711

8.  Changes in renal medulla gene expression in a pre-clinical model of post cardiopulmonary bypass acute kidney injury.

Authors:  Mohamed T Ghorbel; Nishith N Patel; Maimuna Sheikh; Gianni D Angelini; Massimo Caputo; Gavin J Murphy
Journal:  BMC Genomics       Date:  2014-10-21       Impact factor: 3.969

Review 9.  Matrix Metalloproteinases in Non-Neoplastic Disorders.

Authors:  Akinori Tokito; Michihisa Jougasaki
Journal:  Int J Mol Sci       Date:  2016-07-21       Impact factor: 5.923

Review 10.  The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer.

Authors:  László Herszényi; István Hritz; Gábor Lakatos; Mária Zsófia Varga; Zsolt Tulassay
Journal:  Int J Mol Sci       Date:  2012-10-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.